Plus Therapeutics Inc (PSTV) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Plus Therapeutics Inc   (NASDAQ: PSTV)

Plus Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PSTV Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 55.69 % 71.76 % 58.89 %
Gross Margin (Q2 TTM) 65.76 % 55.86 % 68.12 % 51.79 %
Gross Profit Margin 5 Yr. Avg. - 53.99 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) 33.33 % 18.32 % 26.86 % 26.08 %
EBITDA Margin (Q2 TTM) -230.34 % 18.22 % 24.74 % 22.74 %
EBITDA Margin 5 Yr. Avg. - 16.65 % 31.38 % 23.41 %
Operating Margin (Q2 MRQ) -2203.65 % 7.64 % 24.44 % 30.23 %
Operating Margin (Q2 TTM) -628.12 % 11.26 % 21.16 % 22.52 %
Operating Margin 5 Yr. Avg. - 10.04 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 10.38 % 21.91 % 17.76 %
Pre-Tax Profit Margin (Q2 TTM) -241.16 % 10.75 % 18.42 % 15.1 %
Pre-Tax Profit Margin 5 Yr. Avg. - 8.62 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) -2191.24 % 6.33 % 18.03 % 14.44 %
Net Margin (Q2 TTM) -620.7 % 8.12 % 14.93 % 12.18 %
Net Margin 5 Yr. Avg. - 7.42 % 6.08 % 10.8 %



Business Segment Profit Margin
 
Grant
  Explore Grant Segment  -